BIOA vs EVO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

BIOA

39.7
AI Score
VS
EVO Wins

EVO

57.7
AI Score

Investment Advisor Scores

BIOA

40score
Recommendation
AVOID NEW MONEY

EVO

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BIOA EVO Winner
Forward P/E 0 19.6078 Tie
PEG Ratio 0 1.4223 Tie
Revenue Growth 1.6% -16.2% BIOA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.7/100 57.7/100 EVO
Profit Margin 0.0% -27.5% BIOA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD EVO

Relative Price Performance (Last 90 Days)

BIOA 1M: -32.1% · 3M: -73.4% EVO 1M: -15.8% · 3M: -45.2%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -36.9%), weak momentum, RSI 25

RSI (14): 25.1 · Price: $6.61

EVO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.1%), weak momentum, RSI 40

RSI (14): 40.0 · Price: $1.60

Fundamentals Snapshot

Metric BIOA EVO
Market Cap — —
Forward P/E -2.7 22.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.2%
Gross Margin -7.5% 0.1%
Operating Margin -12.0% -0.6%
EPS -2.29 -0.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EVO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.